⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002083206

Tamayo Louis Edward

Reports to the SEC for 1 company · NEW YORK, NY

Transactions

8

Companies

1

Filings

5

CIK

0002083206

Forms 4 and 5

Insider transactions

8 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-24	LXEOLexeo Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+54.8K sh	—	—	54,750
2026-08-18	LXEOLexeo Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−4,117 sh	$4.91	−$20.2K	92,907
2026-07-01	LXEOLexeo Therapeutics, Inc.S Sale	Chief Financial Officer	SSale	−4,641 sh	$4.49	−$20.8K	97,024
2026-06-29	LXEOLexeo Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+12K sh	—	—	101,665
2026-02-04	LXEOLexeo Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+44.7K sh	—	—	89,665
2026-02-04	LXEOLexeo Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+227K sh	—	—	226,665
2025-08-29	LXEOLexeo Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+45K sh	—	—	45,000
2025-08-29	LXEOLexeo Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+280K sh	—	—	280,000

Recent filings

5

Accepted (ET)
Sep 284
Tamayo Louis Edward0002083206-26-000009
SEC(opens sec.gov)
Aug 194
Tamayo Louis Edward0002083206-26-000007
SEC(opens sec.gov)
Jul 14
Tamayo Louis Edward0002083206-26-000005
SEC(opens sec.gov)
Feb 64
Tamayo Louis Edward0002083206-26-000002
SEC(opens sec.gov)
Sep 34
Tamayo Louis Edward0001415889-25-023491
SEC(opens sec.gov)

Companies

1

Lexeo Therapeutics, Inc.Chief Financial OfficerLXEO

Address

C/O LEXEO THERAPEUTICS, INC. 345 PARK AVENUE SOUTH, FLOOR 6

NEW YORK, NY, 10010